Skip to content
Conditions & Health

Hypogonadism

A condition where the body produces insufficient sex hormones (testosterone or estrogen). Growth hormone secretagogues may indirectly support hormonal balance by optimizing GH/IGF-1 axis function.

Frequently Asked Questions

What is Hypogonadism?
A condition where the body produces insufficient sex hormones (testosterone or estrogen). Growth hormone secretagogues may indirectly support hormonal balance by optimizing GH/IGF-1 axis function.
Why is Hypogonadism important in peptide research?
Understanding hypogonadism is important because it represents a health condition where peptide interventions are being actively researched. Knowledge of the underlying pathology helps inform peptide selection and protocol design.

Related Terms

Growth hormone secretagogue

A compound that stimulates the pituitary gland to release growth hormone by activating the ghrelin receptor or GHRH receptor. Includes peptides (ipamorelin, GHRP-2, GHRP-6) and the oral compound MK-677.

IGF-1

Insulin-like growth factor 1, a hormone produced primarily by the liver in response to growth hormone. Mediates many of GH’s anabolic effects including muscle growth, bone density, and tissue repair.

Related Peptide Profiles

CJC-1295

A synthetic growth hormone-releasing hormone (GHRH) analog that stimulates pulsatile GH secretion. Available with or without DAC (Drug Affinity Complex).

Ipamorelin

A selective growth hormone secretagogue that stimulates GH release through the ghrelin receptor with minimal effect on cortisol or prolactin.

← Back to full glossary